featured
2022 Top Story in Eye Care: Selective Laser Trabeculoplasty vs Eye Drops for Glaucoma and Ocular Hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in Glaucoma and Ocular Hypertension Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty Versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension. Ophthalmology. 2022 Sep 16. doi: 10.1016/j.ophtha.2022.09.009. Online ahead of print.
- Nishida T, Moghimi S, Chang AC, et al. Association of Intraocular Pressure With Retinal Nerve Fiber Layer Thinning in Patients With Glaucoma. JAMA Ophthalmol. 2022 Oct 27. doi: 10.1001/jamaophthalmol.2022.4462. Online ahead of print.
- Broadway DC, Grierson I, O'Brien C, et al. Adverse Effects of Topical Antiglaucoma Medication. II. The Outcome of Filtration Surgery. Arch Ophthalmol. 1994;112(11):1446–1454.
- Goldstein MH, Silva FQ, Blender N, et al. Ocular Benzalkonium Chloride Exposure: Problems and Solutions. Eye (Lond). 2022;36(2):361–368.